Determining the optimal PD‐1/PD‐L1 inhibitors for the first‐line treatment of non‐small‐cell lung cancer with high‐level PD‐L1 expression in China

por Teng, Meng‐Meng, Chen, Si‐Ying, Yang, Bo, Wang, Yan, Han, Rui‐Ying, An, Meng‐Na, Dong, Ya‐lin, You, Hai‐Sheng
Publicado 2021

Concordance of Treatment Recommendations for Metastatic Non-Small-Cell Lung Cancer Between Watson for Oncology System and Medical Team

por You, Hai-Sheng, Gao, Chun-Xia, Wang, Hai-Bin, Luo, Sai-Sai, Chen, Si-Ying, Dong, Ya-Lin, Lyu, Jun, Tian, Tao
Publicado 2020